These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24964695)

  • 1. Measurement of costs for health economic evaluation.
    Riewpaiboon A
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S17-26. PubMed ID: 24964695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of costs.
    Riewpaiboon A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S28-37. PubMed ID: 19253485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of economic evaluation results.
    Chaikledkaew U
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S72-80. PubMed ID: 24964702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handling time in economic evaluation studies.
    Permsuwan U; Guntawongwan K; Buddhawongsa P
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S50-8. PubMed ID: 24964699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the scope of health technology assessment and types of health economic evaluation.
    Tanvejsilp P; Ngorsuraches S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S10-6. PubMed ID: 24964694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining types of economic evaluation.
    Ngorsuraches S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard cost lists for health economic evaluation in Thailand.
    Riewpaiboon A
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S127-34. PubMed ID: 24964710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budget impact analysis.
    Leelahavarong P
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S65-71. PubMed ID: 24964701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assessment of health economic evaluation.
    Chaikledkaew U; Kittrongsiri K
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S113-8. PubMed ID: 24964708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of economic evaluation results.
    Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Health Economics' and the evolution of economic evaluation of health technologies.
    Hutton J
    Health Econ; 2012 Jan; 21(1):13-8. PubMed ID: 22147623
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of cost-effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis.
    Iannazzo S; De Francesco M; Gomez-Ulloa D; Benucci M
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):455-68. PubMed ID: 23977974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making health technology assessment information available for decision making: the development of a Thai database.
    Kapol N; Maitreemit P; Chalongsuk R; Amrumpai Y; Sribundit N; Thavorncharoensap M; Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S8-10. PubMed ID: 19253482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of clinical effects.
    Teerawattananon Y; Thavorncharoensap M; Mohara A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transferability of economic data: a difficult endeavor.
    Sullivan SD
    Value Health; 2009 Jun; 12(4):408. PubMed ID: 19900248
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines for health-economic evaluations in Austria].
    Walter E; Zehetmayr S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):628-32. PubMed ID: 17211768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.